Financial reports
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
10 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
Termination of a Material Definitive Agreement
11 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
8 Mar 24
8-K
Other Events
28 Feb 24
8-K
Other Events
22 Feb 24
8-K
Amendments to Articles of Incorporation or Bylaws
29 Jan 24
8-K
Other Events
26 Jan 24
8-K
Entry into a Material Definitive Agreement
8 Jan 24
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Other Events
24 Nov 23
8-K
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9 Nov 23
Registration and prospectus
15-12G
Securities registration termination
21 Mar 24
25-NSE
Exchange delisting
11 Mar 24
POS AM
Prospectus update (post-effective amendment)
11 Mar 24
POS AM
Prospectus update (post-effective amendment)
11 Mar 24
POS AM
Prospectus update (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
Proxies
DEFA14A
Additional proxy soliciting materials
28 Feb 24
DEFA14A
Additional proxy soliciting materials
22 Feb 24
DEFM14A
Proxy related to merger
8 Feb 24
PREM14A
Preliminary proxy related to merger
29 Jan 24
DFAN14A
Additional proxy materials by non-management
10 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
DFAN14A
Additional proxy materials by non-management
8 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
Other
EFFECT
Notice of effectiveness
12 Mar 24
EFFECT
Notice of effectiveness
12 Mar 24
EFFECT
Notice of effectiveness
12 Mar 24
EFFECT
Notice of effectiveness
20 Dec 23
EFFECT
Notice of effectiveness
31 May 23
CORRESP
Correspondence with SEC
25 May 23
UPLOAD
Letter from SEC
24 May 23
EFFECT
Notice of effectiveness
16 May 23
CORRESP
Correspondence with SEC
11 May 23
UPLOAD
Letter from SEC
26 Apr 23
Ownership
SC 13G
GLAZER CAPITAL, LLC
18 Mar 24
SC 13D/A
GAMCO INVESTORS, INC. ET AL
13 Mar 24
4
Vijay K Lathi
11 Mar 24
4
LAUREN P SILVERNAIL
11 Mar 24
4
RONALD HUNT
11 Mar 24
4
Luke Nathaniel Walker
11 Mar 24
4
Scott Dunseth Myers
11 Mar 24
4
Mark Chin
11 Mar 24
4
JONATHAN G DRACHMAN
11 Mar 24
4
Andrew R Robbins
11 Mar 24